Drug Discovery and Development

Drug discovery CRO Domainex opens facility in UK

By |

DomainexDomainex Ltd. has opened a new facility over 7,000 ft2 in size at Unity Campus in Sawston, UK, approximately seven miles from Cambridge.

Unity Campus is a science and technology park with business, R&D and lab space.

Domainex’s new facilities there house a dedicated suite of labs.

Domainex is aiming to hire new staff from a variety of disciplines. It aims to boost its headcount by up to 50% by the end of the year.

The opening of the new site has “the added benefit of freeing up space at our closely located Chesterford Research Park site to further expand our chemistry group,” said Dr. Tom Mander, CEO of Domainex.

Domainex was founded in 2001 as a spin-out from University College London, Birkbeck College and the Institute of Cancer Research.

It offers a variety of services ranging from disease target selection to pre-clinical candidate selection.

Lab expansion image

Unity Campus lab expansion image courtesy of Domainex.

Filed Under: Drug Discovery
Tagged With: , , ,
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Related Articles Read More >

Search Drug Discovery & Development